Aldeyra Therapeutics, Inc.

ALDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Aug 10, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Aug 9, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Aug 8, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Aug 5, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
10-Q Aug 5, 2022 10-Q
8-K Aug 5, 2022 ALDEYRA THERAPEUTICS, INC. 8-K
4 Aug 4, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Aug 3, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Aug 2, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Aug 1, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Jul 19, 2022 FORM 4 SUBMISSION
4 Jul 19, 2022 FORM 4 SUBMISSION
4 Jul 19, 2022 FORM 4 SUBMISSION
8-K Jul 12, 2022 ALDEYRA THERAPEUTICS, INC. 8-K
SC 13G Jul 8, 2022
4 Jun 27, 2022 FORM 4 SUBMISSION
4 Jun 27, 2022 FORM 4 SUBMISSION
4 Jun 9, 2022 FORM 4 SUBMISSION
4 Jun 9, 2022 FORM 4 SUBMISSION
4 Jun 9, 2022 FORM 4 SUBMISSION
4 Jun 9, 2022 FORM 4 SUBMISSION
4 Jun 9, 2022 FORM 4 SUBMISSION
4 Jun 9, 2022 FORM 4 SUBMISSION
8-K Jun 8, 2022 ALDEYRA THERAPEUTICS, INC. 8-K
8-K May 24, 2022 ALDEYRA THERAPEUTICS, INC. 8-K
← Newer Page 8 of 26 · 646 filings Older →